TrialThoracic cancer2016

Continuous infusion of high-dose ulinastatin during surgery does not improve early postoperative clinical outcomes in patients undergoing radical lung cancer surgery: A pilot study.

Leng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.